IFG Advisory’s Array Biopharma Inc ARRY Stock Holding History

IFG Advisory’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,647	Closed	-$1.88M	–	460
2019 Q2	$1.88M	Sell	40,647 -700	-2%	-$19.7K	0.33%	68
2019 Q1	$1.01M	Sell	41,347 -111	-0.3%	-$2.31K	0.19%	114
2018 Q4	$590K	Sell	41,458 -6,867	-14%	-$104K	0.14%	152
2018 Q3	$734K	Buy	48,325 +6,132	+15%	+$94K	0.14%	146
2018 Q2	$707K	Buy	42,193 +4,076	+11%	+$64.8K	0.15%	144
2018 Q1	$622K	Sell	38,117 -6,337	-14%	-$102K	0.14%	151
2017 Q4	$569K	Buy	+44,454	New	+$506K	0.13%	158

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

IFG Advisory's ARRY Position: Q3 2019 in Review

IFG Advisory sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 40,647 shares — an estimated $1.88M sold.

IFG Advisory first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $1.88M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

IFG Advisory reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
IFG Advisory sold 40,647 Array Biopharma Inc shares in Q3 2019, an estimated $1.88M.
IFG Advisory first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
IFG Advisory's Array Biopharma Inc position peaked at $1.88M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on IFG Advisory's 13F filing for Q3 2019, filed 6 Nov 2019.